percentage of qualifying intellectual property income subject to concessionary rate |
1. For the purposes of regulation 3, the percentage of qualifying intellectual property income from an elected qualifying IPR is determined in accordance with the formula |
| (a) | C is the sum total of the following expenditures, less excluded expenditures:| (i) | expenditure incurred in the period with records by the approved company (except under a cost‑sharing agreement) —| (A) | for connected R and D carried out directly by the approved company; and | | (B) | for connected R and D carried out on behalf of the approved company by —| (BA) | a person that is not a related party of the approved company; or | | (BB) | a person resident in Singapore that is a related party of the approved company, where the research and development is carried out in Singapore; |
|
| | (ii) | payments made in the period with records by the approved company under a cost‑sharing agreement (not being an excluded cost‑sharing agreement) to carry out connected R and D; and |
| | (b) | D is the sum total of the following expenditures, less excluded expenditures:| (i) | expenditure incurred in the period with records by the approved company (except under a cost‑sharing agreement) in obtaining from another person (whether by acquisition, licensing, amalgamating with another company or otherwise), a specified right; | | (ii) | expenditure incurred in the period with records by the approved company (except under a cost‑sharing agreement) for connected R and D carried out on behalf of the approved company by a person that is a related party of the approved company, where the person is not resident in Singapore or the research and development is not carried out in Singapore; | | (iii) | payments made in the period with records by the approved company under an excluded cost‑sharing agreement to carry out connected R and D; | | (iv) | payments made in the period with records by the approved company in order to become a party to a cost‑sharing agreement, to the extent that such payments were made to obtain a specified right. |
|
|
2. For the purpose of calculating the percentage in paragraph 1 —| (a) | where any expenditure mentioned in paragraph 1(a) or (b) was incurred by the approved company for connected R and D that was connected to the elected qualifying IPR and any other qualifying IPR, the amount of the expenditure must be apportioned to each of the elected qualifying IPRs according to the extent to which the expenditure was incurred in relation to each IPR; | | (b) | in a case where the elected qualifying IPR is not a family of qualifying IPRs and the approved company ceases to have the qualifying IPR at any time during the subject basis period, the expenditure mentioned in paragraph 1(a) or (b) is such expenditure that is incurred up to (and including) the day of such cessation; | | (c) | in a case where the elected qualifying IPR is a family of qualifying IPRs, the expenditure mentioned in paragraph 1(a) or (b) are those that are identifiable as being incurred in relation to the following IPRs:| (i) | those qualifying IPRs in the elected family that the approved company still has as of the last day of the subject basis period; | | (ii) | if the approved company does not have any of those qualifying IPRs on the last day of the subject basis period — all of those qualifying IPRs if the company ceases to have them on the same day, or the last of those qualifying IPRs that the company ceases to have if the company ceases to have them on different days; and |
| | (d) | except as provided in paragraph 1(b)(iv), a reference in paragraph 1(a) or (b) to a payment made by an approved company under a cost‑sharing agreement does not include any payment made in order for the approved company to become a party to the cost‑sharing agreement. |
|
| 3. If the percentage calculated under paragraph 1 is more than 100%, it is treated as 100%. |
4. Where —| (a) | the approved company obtains a specified right by amalgamating with another company having the right that is resident in Singapore; or | | (b) | the approved company —| (i) | acquires all equity interests in another company that is resident in Singapore and owns a specified right prior to the acquisition; and | | (ii) | subsequently acquires or licenses the specified right from the other company, |
|
| and the other company has records in relation to the specified right that satisfy the requirements of regulation 6 (modified by substituting the reference to an approved company with the other company) for the whole period where that other company carried out research and development connected to the specified right, then C and D are modified in accordance with paragraph 5. |
|
5. For the purposes of paragraph 4, C and D are modified by substituting C with “C + C1” and D with “D + D1 – D2”, where —| (a) | C1 is the amount of C if each reference to the approved company in paragraph 1(a) were substituted with a reference to the other company mentioned in paragraph 4(a) or (b); | | (b) | D1 is the amount of D if each reference to the approved company in paragraph 1(b) were substituted with a reference to that other company; and | | (c) | D2 is the expenditure incurred by the approved company in obtaining the specified right. |
|
| 6. To avoid doubt, paragraph 2 applies for the purpose of determining the amount of C and D in paragraph 4, as modified in accordance with paragraph 5. |
7. In this Schedule —| “connected R and D” means any research and development connected to the elected qualifying IPR; |
| “equity interest”, in relation to a company, means an issued share in the company that is not a treasury share; |
“excluded cost‑sharing agreement” means a cost‑sharing agreement under which none of the research and development that is the subject of the cost‑sharing agreement is carried out —| (a) | by the approved company itself; or | | (b) | on behalf of the approved company by a person (not being another party to the cost‑sharing agreement) that —| (i) | in a case where the research and development is carried out in Singapore — is resident in Singapore and a related party of the approved company; or | | (ii) | in any other case — is not a related party of the approved company; |
|
|
“excluded expenditure” means —| (a) | an interest payment; | | (b) | any deductible borrowing costs mentioned in the Income Tax (Deductible Borrowing Costs) Regulations 2008 (G.N. No. S 115/2008); or | | (c) | a payment for any land or building, or for any alteration, addition or extension to any building; |
|
“period with records”, in relation to an approved company, means the period —| (a) | from and including the approval date of the approved company; and | | (b) | up to and including the last day of the subject basis period, |
| and, if the approved company has records for any period that ends immediately before the approval date that satisfy the requirements of regulation 6 (read as if a reference to an approved company were a reference to the approved company before its approval), inclusive of that period; |
|
“specified right” means —| (a) | the elected qualifying IPR; or | | (b) | any qualifying IPR on which the approved company has carried out connected R and D. |
|
|
|